15th
February
2021
Faster to the right antibiotic treatment - Resistell in Schweizerische Ärztezeitung
How do you find the most effective antibiotic for a patient as quickly as possible? The start-up "Resistell" has developed a new type of test for antibiotic resistance. Read more about this test in Schwizerische Ärztezeitung.
11th
February
2021
International Day of Women and Girls in Science - European Innovation Council interview with Danuta Cichocka
On the International Day of Women and Girls in Science, European Innovation Council invited Danuta Cichocka, Resistell CEO, the female scientist and entrepreneur, to share her story about her passion in life science in an interview.
10th
February
2021
Aus welchem Holz sind Gründerinnen und Gründer geschnitzt?
Die Covid-Pandemie hat alle Bereiche des Lebens erfasst. Auch die Startup- und Gründerszene musste mit der Situation umgehen und unter erschwerten Bedingungen die Projekte weiter führen und antreiben. Gleichzeitig aber hat Corona als Katalysator gewirkt für disruptive Ideen, für Innovation und Unternehmergeist.
7th
January
2021
Venturelab's series about Switzerland’s most inspiring entrepreneurs and founders continues with Danuta Cichocka, the co-founder and CEO of Resistell AG.
The Muttenz-based biotech startup proposes an alternative to culture-based antibiograms, the current gold standard in antibiotic susceptibility testing. The EPFL spin-off offers a diagnostic device, the rapid AST method, which is based on the detection of movement caused by living bacterial cells. The new method reduces the time taken to get a result from days to minutes, shows which specific antibiotic is effective against the bacteria, and significantly improves the chances of patients’ survival.
image source:
HEMEX AG
19th
November
2020
Antimicrobials: handle with care by HEMEX
The World Antimicrobial Awareness Week (WAAW) starts today, and this year’s slogan highlights the importance of encouraging best practices when it comes to using antimicrobials. Our portfolio company Resistell is helping to reduce the spreading of antibiotic resistance with their rapid Antimicrobial Susceptibility Testing.
16th
November
2020
Resistell wins Special Life Science Award in Swiss Innovation Challenge 2020
Resistell, the start-up developing world’s fastest phenotypic antibiotic susceptibility test (rapid AST) won the Special Life Science Award in Swiss Innovation Challenge. The prestigious award is a great honour for Resistell and a huge confirmation for the whole team and the product itself.
3rd
July
2020
Resistell AG receives €2.5M EIC Accelerator grant and equity financing offer from EIC
Resistell AG, the start-up developing world’s fastest phenotypic antibiotic susceptibility test was selected for funding under the European Innovation Council (EIC) programme in the latest funding round. Resistell’s project RAPID-SEP-AST will receive up to €2.5M grant and additional equity financing from EIC Fund.
19th
June
2020
Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection
We invite you to study the "Current and near-future technologies for antibiotic susceptibility testing and resistant bacteria detection" published in TrAC Trends in Analytical Chemistry, Volume 127, June 2020 by Jiri Dietvorst, Luïsa Vilaplana, Naroa Uria, Maria-Pilar Marco, Xavier Muñoz-Berbel.
8th
June
2020
Top100 Startup 2020 public voting has began, vote for Resistell
Resistell, EPFL spinoff, located on the brand new 5th floor in Muttenz, is developing world’s fastest antibiotic susceptibility test to help the physicians around the world save patients lives. Our solution is needed more than ever in the context of global pandemics. Last year we have secured CHF 3.5 M in equity financing and won Innosuisse and Eurostars grants. Our core team counts 10 people and we expect to grow further in the next months. Last year we were 34th and among top 5 newcomers on the Top 100 Swiss Startups list. Help us climb faster to the top! Vote now!
